Biotech IPOs lead 2026 US market, overshadowing AI firms like Anthropic
Biotech IPOs have taken the lead in the 2026 US IPO market with a 55% weighted average gain, outperforming the broader market's 4.4% loss and overshadowing AI firms like Anthropic and OpenAI. The market for Anthropic's I…